Robert J. Schneider, PhD

Associate Dean for Therapeutics Alliances

Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology

Professor, Department of Radiation Oncology

cancer, developmental genetics, genome integrity, microbiology, pharmacology, RNA biology, stem cell biology

I am an Associate Director of the NYU Cancer Institute, Director of Translational Cancer Research, and Co-director of the Breast Cancer Research Program at NYU School of Medicine. Our research is directed to three major areas: (1) the molecular and genetic understanding of advanced breast cancers and the development of new treatment strategies and therapeutics for advanced breast cancers, focusing particularly on the role of protein synthesis and mTOR kinase regulation; (2) the molecular understanding of gene regulation by ionizing radiation, particularly its ability to regulate protein synthesis and use of this knowledge for development of new cancer treatment strategies; and (3) regulation of the inflammatory response by targeted rapid degradation of inflammatory cytokine mRNAs, and the connection to cancer development and progression.





Academic office

450 East 29th Street

New York, NY 10016

Lab Website
Is this your profile?
These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication

Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology

Professor, Department of Radiation Oncology

Associate Dean for Therapeutics Alliances

Fellowship, SUNY Stony Brook/Princeton University, Virology-Virus-cell Interactions

PhD from Mount Sinai School of Medicine

Goldman, Kara N; Chenette, Devon; Arju, Rezina; Duncan, Francesca E; Keefe, David L; Grifo, Jamie A; Schneider, Robert J

Proceedings of the National Academy of Sciences of the United States of America (PNAS). 2017 Mar 7; 114(12):3186-3191

Translational control pathways form a molecular hub that regulates tamoxifen resistance in ER plus breast cancer [Meeting Abstract]

Geter, Phillip A; Schneider, Robert J

Cancer research. 2017 MAR; 77:?-?

Silvera, Deborah; Ernlund, Amanda; Arju, Rezina; Connolly, Eileen; Volta, Viviana; Wang, Jinhua; Schneider, Robert J

Molecular & cellular biology. 2017 Feb 15; 37(5):?-?

Dhage, S; Ernlund, A; Wang, J; Axelrod, D; Berman, R; Roses, D; Schneider, R

Cancer research. 2017 FEB; 77:?-?

Dankert, John F; Rona, Gergely; Clijsters, Linda; Geter, Phillip; Skaar, Jeffrey R; Bermudez-Hernandez, Keria; Sassani, Elizabeth; Fenyo, David; Ueberheide, Beatrix; Schneider, Robert; Pagano, Michele

Molecular cell. 2016 Nov 03; 64(3):507-519

MTOR inhibitors preserve fertility in a murine model: A novel pharmacologic approach to fertility preservation during gonadotoxic chemotherapy [Meeting Abstract]

Goldman, K N; Chenette, D; Keefe, D L; Grifo, J; Schneider, R J

Fertility & sterility. 2016 Sep; Conference:(ASRM):e2-e3

Chenette, Devon M; Cadwallader, Adam B; Antwine, Tiffany L; Larkin, Lauren C; Wang, Jinhua; Olwin, Bradley B; Schneider, Robert J

Cell reports. 2016 Aug 02; 16(5):1379-1390

Morfoisse, Florent; Tatin, Florence; Hantelys, Fransky; Adoue, Aurelien; Helfer, Anne-Catherine; Cassant-Sourdy, Stephanie; Pujol, Francoise; Gomez-Brouchet, Anne; Ligat, Laetitia; Lopez, Frederic; Pyronnet, Stephane; Courty, Jose; Guillermet-Guibert, Julie; Marzi, Stefano; Schneider, Robert J; Prats, Anne-Catherine; Garmy-Susini, Barbara H

Cancer research. 2016 Aug 01; 76(15):4394-4405